Free Trial
→ Can you still profit from AI this year? (Read this ASAP) (From Weiss Ratings) (Ad) Buy HIPO Stock  Free HIPO Stock Alerts

Hippo (HIPO) Financials

Hippo logo
$24.38 -0.23 (-0.95%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$24.36 -0.02 (-0.07%)
As of 04/17/2025 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Hippo

Annual Income Statements for Hippo

This table shows Hippo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -371 -333 -273 -41
Consolidated Net Income / (Loss)		 -368 -327 -263 -29
Net Income / (Loss) Continuing Operations		 -169 -327 -263 -29
Total Pre-Tax Income 		-367 -325 -263 -27
Total Operating Income		 -215 -328 -263 -82
Total Gross Profit		 -35 -42 -51 74
Total Revenue		 91 120 210 372
Operating Revenue		 91 120 210 372
Total Cost of Revenue		 126 161 261 298
Operating Cost of Revenue		 126 161 261 298
Total Operating Expenses		 180 286 212 156
Selling, General & Admin Expense		 49 72 80 71
Marketing Expense		 95 102 80 51
Research & Development Expense		 36 58 47 31
Restructuring Charge		 0.00 55 5.50 3.60
Total Other Income / (Expense), net		 47 0.00 0.00 54
Other Income / (Expense), net		 - 0.00 0.00 54
Income Tax Expense		 0.70 1.30 0.50 1.20
Net Income / (Loss) Attributable to Noncontrolling Interest		 3.50 6.90 10 12
Basic Earnings per Share		 ($34.11) ($14.66) ($11.58) ($1.64)
Weighted Average Basic Shares Outstanding		 10.89M 22.75M 23.58M 24.70M
Diluted Earnings per Share		 ($34.11) ($14.66) ($11.58) ($1.64)
Weighted Average Diluted Shares Outstanding		 10.89M 22.75M 23.58M 24.70M
Weighted Average Basic & Diluted Shares Outstanding		 566.27M 23.31M 24.31M 25.08M

Quarterly Income Statements for Hippo

This table shows Hippo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Net Income / (Loss) Attributable to Common Shareholders		 -129 -63 -70 -108 -53 -42 -36 -8.50
Consolidated Net Income / (Loss)		 -128 -61 -68 -105 -50 -39 -33 -5.20
Net Income / (Loss) Continuing Operations		 -128 -61 -68 -105 -50 -39 -33 -5.20
Total Pre-Tax Income 		-127 -60 -68 -105 -51 -39 -33 -5.20
Total Operating Income		 -127 -61 -68 -105 -51 -40 -33 -5.20
Total Gross Profit		 -8.80 -3.70 -14 -48 0.90 9.50 12 21
Total Revenue		 31 36 40 48 58 65 85 96
Operating Revenue		 31 36 40 48 58 65 85 96
Total Cost of Revenue		 40 40 54 96 57 55 73 74
Operating Cost of Revenue		 40 40 54 96 57 55 73 74
Total Operating Expenses		 119 57 54 57 52 50 45 27
Selling, General & Admin Expense		 19 18 20 22 21 18 18 15
Marketing Expense		 29 28 22 23 19 16 14 13
Research & Development Expense		 15 12 12 13 12 10 8.30 7.00
Other Operating Expenses / (Income)		 - - - 0.00 0.00 - - -0.10
Restructuring Charge		 55 - 0.00 0.00 0.00 5.50 3.60 0.00
Other Special Charges / (Income)		 - - - - 0.00 - - -8.20
Total Other Income / (Expense), net		 0.10 -1.40 0.00 0.00 0.00 - 0.00 0.00
Income Tax Expense		 0.30 0.50 0.30 0.20 -0.30 0.30 0.20 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 1.70 2.60 1.70 2.60 2.80 3.00 2.60 3.30
Basic Earnings per Share		 ($5.66) ($2.77) ($3.01) ($4.61) ($2.24) ($1.80) ($1.47) ($0.34)
Weighted Average Basic Shares Outstanding		 22.84M 22.75M 23.20M 23.39M 23.73M 23.58M 24.23M 25.07M
Diluted Earnings per Share		 ($5.66) ($2.77) ($3.01) ($4.61) ($2.24) ($1.80) ($1.47) ($0.34)
Weighted Average Diluted Shares Outstanding		 22.84M 22.75M 23.20M 23.39M 23.73M 23.58M 24.23M 25.07M
Weighted Average Basic & Diluted Shares Outstanding		 23.06M 23.31M 23.26M 23.67M 23.89M 24.31M 24.43M 24.36M

Annual Cash Flow Statements for Hippo

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Net Change in Cash & Equivalents		 326 -574 -49 38
Net Cash From Operating Activities		 -125 -162 -92 48
Net Cash From Continuing Operating Activities		 -125 -162 -92 48
Net Income / (Loss) Continuing Operations		 -368 -327 -263 -29
Consolidated Net Income / (Loss)		 -368 -327 -263 -29
Depreciation Expense		 11 15 20 23
Non-Cash Adjustments To Reconcile Net Income		 241 180 188 99
Changes in Operating Assets and Liabilities, net		 -29 -30 -37 -46
Net Cash From Investing Activities		 -30 -406 58 30
Net Cash From Continuing Investing Activities		 -30 -406 58 30
Purchase of Property, Plant & Equipment		 -14 -20 -47 -12
Purchase of Investments		 -26 -793 -410 -368
Divestitures		 - 0.00 0.00 73
Sale and/or Maturity of Investments		 17 409 517 337
Other Investing Activities, net		 -2.90 -2.00 -3.20 0.20
Net Cash From Financing Activities		 481 -6.80 -15 -40
Net Cash From Continuing Financing Activities		 481 -6.80 -15 -40
Repurchase of Common Equity		 - 0.00 -1.80 -16
Payment of Dividends		 - -5.30 -9.60 -20
Issuance of Common Equity		 - 4.10 2.80 6.70
Other Financing Activities, net		 482 -5.60 -6.00 -11

Quarterly Cash Flow Statements for Hippo

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Net Change in Cash & Equivalents		 68 -148 -24 18 31 -74 68 -43
Net Cash From Operating Activities		 -43 -30 -36 -9.30 1.10 -49 18 -11
Net Cash From Continuing Operating Activities		 -43 -30 -36 -9.30 1.10 -49 18 -11
Net Income / (Loss) Continuing Operations		 -128 -61 -68 -105 -50 -39 -33 -37
Consolidated Net Income / (Loss)		 -128 -61 -68 -105 -50 -39 -33 -37
Depreciation Expense		 3.80 4.00 4.30 5.20 4.90 5.40 5.60 5.90
Non-Cash Adjustments To Reconcile Net Income		 88 57 48 99 50 -8.80 59 33
Changes in Operating Assets and Liabilities, net		 -7.50 -31 -20 -7.90 -3.80 -5.80 -14 -12
Net Cash From Investing Activities		 113 -115 14 35 31 -22 59 -28
Net Cash From Continuing Investing Activities		 113 -115 14 35 31 -22 59 -28
Purchase of Property, Plant & Equipment		 -5.50 -3.50 -3.90 -34 -4.70 -4.50 -3.40 -3.80
Purchase of Investments		 -237 -148 -111 -96 -84 -119 -55 -84
Sale and/or Maturity of Investments		 355 36 130 165 119 104 117 60
Net Cash From Financing Activities		 -1.10 -3.10 -1.90 -8.00 -0.90 -3.80 -8.00 -4.40
Net Cash From Continuing Financing Activities		 -1.10 -3.10 -1.90 -8.00 -1.00 -3.70 -8.00 -4.40
Payment of Dividends		 - -3.10 -0.60 -5.80 -0.10 -3.10 -7.60 -2.70
Issuance of Common Equity		 0.10 0.70 0.20 1.70 0.50 0.40 1.00 1.20
Other Financing Activities, net		 -1.20 -1.70 -1.30 -2.30 -1.40 -1.00 -1.40 -2.90

Annual Balance Sheets for Hippo

This table presents Hippo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Total Assets		 1,643 1,569 1,525 1,543
Total Current Assets		 841 627 287 365
Cash & Equivalents		 776 195 142 198
Accounts Receivable		 57 107 145 167
Plant, Property, & Equipment, net		 0.00 0.00 162 206
Plant, Property & Equipment, gross		 - - 162 206
Total Noncurrent Assets		 802 942 1,076 973
Long-Term Investments		 55 121 187 168
Intangible Assets		 58 66 76 65
Other Noncurrent Operating Assets		 635 756 813 740
Total Liabilities & Shareholders' Equity		 1,643 1,569 1,525 1,543
Total Liabilities		 781 975 1,140 1,178
Total Current Liabilities		 516 629 696 686
Accrued Expenses		 95 128 114 87
Other Current Liabilities		 420 501 583 599
Total Noncurrent Liabilities		 265 346 444 492
Other Noncurrent Operating Liabilities		 265 346 444 492
Commitments & Contingencies		 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 862 594 385 365
Total Preferred & Common Equity		 860 590 378 362
Total Common Equity		 860 590 378 362
Common Stock		 1,488 1,558 1,615 1,640
Retained Earnings		 -628 -961 -1,234 -1,275
Accumulated Other Comprehensive Income / (Loss)		 -0.70 -7.00 -2.90 -2.70
Noncontrolling Interest		 2.10 3.60 6.80 3.10

Quarterly Balance Sheets for Hippo

This table presents Hippo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024
Total Assets		 1,630 1,605 1,681 1,647 1,496 1,545
Total Current Assets		 658 613 577 562 502 743
Cash & Equivalents		 347 189 200 228 223 191
Restricted Cash		 - - - - - 40
Short-Term Investments		 222 290 229 189 125 354
Accounts Receivable		 90 134 148 145 154 158
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 972 992 1,104 1,085 994 802
Intangible Assets		 65 67 69 71 75 74
Other Noncurrent Operating Assets		 798 784 899 873 757 728
Total Liabilities & Shareholders' Equity		 1,630 1,605 1,681 1,647 1,496 1,545
Total Liabilities		 991 1,062 1,234 1,236 1,142 1,215
Total Current Liabilities		 661 687 798 776 705 710
Accrued Expenses		 124 133 128 125 105 98
Other Current Liabilities		 537 555 670 651 600 612
Total Noncurrent Liabilities		 330 374 436 460 436 505
Other Noncurrent Operating Liabilities		 330 374 436 460 436 505
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 639 543 447 411 355 330
Total Preferred & Common Equity		 635 538 446 407 351 326
Total Common Equity		 635 538 446 407 351 326
Common Stock		 1,541 1,575 1,591 1,606 1,625 1,645
Retained Earnings		 -898 -1,031 -1,139 -1,192 -1,270 -1,319
Accumulated Other Comprehensive Income / (Loss)		 -7.80 -5.30 -6.40 -7.10 -3.40 0.50
Noncontrolling Interest		 4.00 4.70 1.40 4.30 3.60 3.70

Annual Metrics and Ratios for Hippo

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric 2021 2022 2023 2024
Growth Metrics		 - - - -
Revenue Growth		 76.74% 31.25% 75.19% 77.44%
EBITDA Growth		 39.76% -69.93% 22.08% 98.23%
EBIT Growth		 30.99% -52.21% 19.65% 89.56%
NOPAT Growth		 -83.70% -52.21% 19.65% 68.89%
Net Income Growth		 -160.18% 11.25% 19.45% 89.13%
EPS Growth		 -160.18% 57.02% 21.01% 85.84%
Operating Cash Flow Growth		 -90.37% -29.72% 42.79% 151.41%
Free Cash Flow Firm Growth		 0.00% 38.97% -78.76% 99.36%
Invested Capital Growth		 124.56% -312.22% 218.34% -100.00%
Revenue Q/Q Growth		 0.00% 3.28% 15.86% 0.00%
EBITDA Q/Q Growth		 0.00% 1.11% 8.39% 0.00%
EBIT Q/Q Growth		 0.00% 0.85% 7.35% 0.00%
NOPAT Q/Q Growth		 0.00% 0.85% 7.35% 0.00%
Net Income Q/Q Growth		 0.00% -0.34% 7.43% 0.00%
EPS Q/Q Growth		 0.00% -1.10% 6.46% 0.00%
Operating Cash Flow Q/Q Growth		 16.05% -18.14% -24.86% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% -218.07% 0.00%
Invested Capital Q/Q Growth		 0.00% -22.45% 137.73% 0.00%
Profitability Metrics		 - - - -
Gross Margin		 -38.27% -34.75% -24.37% 19.97%
EBITDA Margin		 -201.64% -261.07% -116.12% -1.16%
Operating Margin		 -236.07% -273.77% -125.56% -22.01%
EBIT Margin		 -236.07% -273.77% -125.56% -7.39%
Profit (Net Income) Margin		 -403.40% -272.77% -125.42% -7.69%
Tax Burden Percent		 100.19% 100.40% 100.19% 104.38%
Interest Burden Percent		 170.55% 99.24% 99.70% 99.64%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% -4,286.28% -206.59%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% -4,270.05% -214.87%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 4,232.51% 198.97%
Return on Equity (ROE)		 -73.07% -44.87% -53.77% -7.63%
Cash Return on Invested Capital (CROIC)		 -1,189.19% 0.00% -516.59% -6.59%
Operating Return on Assets (OROA)		 -16.42% -20.41% -17.02% -1.79%
Return on Assets (ROA)		 -28.06% -20.33% -17.00% -1.86%
Return on Common Equity (ROCE)		 -47.89% -44.70% -53.20% -7.53%
Return on Equity Simple (ROE_SIMPLE)		 -42.80% -55.35% -69.60% -7.90%
Net Operating Profit after Tax (NOPAT)		 -151 -229 -184 -57
NOPAT Margin		 -165.25% -191.64% -87.89% -15.41%
Net Nonoperating Expense Percent (NNEP)		 -40.41% -13.12% -16.23% 8.27%
Return On Investment Capital (ROIC_SIMPLE)		 - -38.65% -47.91% -15.70%
Cost of Revenue to Revenue		 138.27% 134.75% 124.37% 80.03%
SG&A Expenses to Revenue		 53.95% 59.73% 37.96% 19.00%
R&D to Revenue		 39.69% 48.04% 22.41% 8.25%
Operating Expenses to Revenue		 197.81% 239.01% 101.19% 41.98%
Earnings before Interest and Taxes (EBIT)		 -215 -328 -263 -28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -184 -313 -244 -4.30
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 1.85 0.53 0.58 1.80
Price to Tangible Book Value (P/TBV)		 2.13 0.60 0.72 2.20
Price to Revenue (P/Rev)		 17.46 2.62 1.04 1.75
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 34.16 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 8.28 0.00 0.00 0.78
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 6.11
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00
Financial Leverage		 -1.07 -1.02 -0.99 -0.93
Leverage Ratio		 2.60 2.21 3.16 4.09
Compound Leverage Factor		 4.44 2.19 3.15 4.08
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.24% 0.61% 1.77% 0.85%
Common Equity to Total Capital		 99.76% 99.39% 98.23% 99.15%
Debt to EBITDA		 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Altman Z-Score		 0.55 -1.28 -1.77 -0.89
Noncontrolling Interest Sharing Ratio		 34.46% 0.39% 1.06% 1.32%
Liquidity Ratios		 - - - -
Current Ratio		 1.63 1.00 0.41 0.53
Quick Ratio		 1.63 1.00 0.41 0.53
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 -263 -160 -287 -1.83
Operating Cash Flow to CapEx		 -882.98% -819.80% -197.86% 395.83%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 0.07 0.07 0.14 0.24
Accounts Receivable Turnover		 1.95 1.46 1.66 2.38
Inventory Turnover		 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 2.03
Accounts Payable Turnover		 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 187.30 249.58 219.66 153.12
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 187.30 249.58 219.66 153.12
Capital & Investment Metrics		 - - - -
Invested Capital		 22 -47 56 0.00
Invested Capital Turnover		 -2.69 -9.65 48.77 13.41
Increase / (Decrease) in Invested Capital		 112 -69 102 -56
Enterprise Value (EV)		 755 -323 -105 290
Market Capitalization		 1,592 314 218 652
Book Value per Share		 $1.53 $25.58 $15.82 $14.86
Tangible Book Value per Share		 $1.33 $22.73 $12.65 $12.19
Total Capital		 862 594 385 365
Total Debt		 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00
Net Debt		 -840 -640 -329 -365
Capital Expenditures (CapEx)		 14 20 47 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -459 -522 -551 -519
Debt-free Net Working Capital (DFNWC)		 326 -2.60 -409 -321
Net Working Capital (NWC)		 326 -2.60 -409 -321
Net Nonoperating Expense (NNE)		 217 97 79 -29
Net Nonoperating Obligations (NNO)		 -840 -640 -329 -365
Total Depreciation and Amortization (D&A)		 31 15 20 23
Debt-free, Cash-free Net Working Capital to Revenue		 -503.40% -436.01% -262.71% -139.48%
Debt-free Net Working Capital to Revenue		 357.02% -2.17% -194.95% -86.37%
Net Working Capital to Revenue		 357.02% -2.17% -194.95% -86.37%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 ($34.00) ($14.66) ($11.58) ($1.64)
Adjusted Weighted Average Basic Shares Outstanding		 10.89M 22.75M 23.58M 24.70M
Adjusted Diluted Earnings per Share		 ($34.00) ($14.66) ($11.58) ($1.64)
Adjusted Weighted Average Diluted Shares Outstanding		 10.89M 22.75M 23.58M 24.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 22.65M 23.31M 24.31M 25.08M
Normalized Net Operating Profit after Tax (NOPAT)		 -151 -191 -180 -55
Normalized NOPAT Margin		 -165.25% -159.30% -86.06% -14.73%
Pre Tax Income Margin		 -402.63% -271.68% -125.18% -7.36%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% -1.62% -3.65% -71.33%
Augmented Payout Ratio		 0.00% -1.62% -4.33% -125.87%

Quarterly Metrics and Ratios for Hippo

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Growth Metrics		 - - - - - - - -
Revenue Growth		 44.13% 11.88% 62.45% 66.20% 87.95% 80.17% 113.82% 100.21%
EBITDA Growth		 -418.49% 3.47% -1.28% -46.33% 62.97% 40.51% 56.80% 100.70%
EBIT Growth		 -326.85% 2.19% -1.81% -46.44% 60.22% 35.68% 51.26% 95.05%
NOPAT Growth		 -126.51% 4.38% -0.30% -45.83% 60.25% 34.21% 51.26% 95.05%
Net Income Growth		 -326.42% -1.85% -2.41% -46.11% 60.55% 34.88% 51.40% 95.06%
EPS Growth		 -326.42% 50.36% 0.00% -41.85% 60.42% 35.02% 51.16% 92.62%
Operating Cash Flow Growth		 14.00% -467.92% 39.08% 68.79% 102.56% -61.13% 149.58% -13.98%
Free Cash Flow Firm Growth		 102.37% 0.00% -46.14% -52.69% 3,250.68% -597.67% -16.35% 110.14%
Invested Capital Growth		 -172.26% -312.22% -311.78% -700.00% -284.07% 218.34% -101.81% -116.92%
Revenue Q/Q Growth		 6.97% 16.61% 11.17% 19.85% 20.96% 11.79% 31.94% 12.22%
EBITDA Q/Q Growth		 -80.94% 52.59% -10.68% -57.91% 54.21% 23.85% 21.55% 102.56%
EBIT Q/Q Growth		 -77.41% 50.86% -10.47% -55.56% 51.81% 20.55% 18.16% 84.19%
NOPAT Q/Q Growth		 -76.81% 52.00% -10.47% -55.56% 51.81% 20.55% 18.16% 84.19%
Net Income Q/Q Growth		 -77.08% 52.55% -12.56% -54.48% 52.19% 21.67% 15.99% 84.29%
EPS Q/Q Growth		 -77.08% 51.06% -8.66% -53.16% 51.41% 19.64% 18.33% 76.87%
Operating Cash Flow Q/Q Growth		 -44.30% 30.00% -18.60% 73.95% 111.83% -4,509.09% 136.49% -159.89%
Free Cash Flow Firm Q/Q Growth		 -98.37% 1,097.72% 153.72% -4.28% 15.20% -277.90% -33.85% 140.45%
Invested Capital Q/Q Growth		 -295.41% -22.45% -64.82% -52.13% -25.09% 137.73% 2.01% -63.53%
Profitability Metrics		 - - - - - - - -
Gross Margin		 -28.66% -10.34% -34.42% -100.21% 1.56% 14.73% 13.75% 22.30%
EBITDA Margin		 -401.95% -163.41% -158.79% -209.22% -79.20% -53.95% -32.08% 0.73%
Operating Margin		 -414.66% -170.67% -169.60% -220.13% -87.70% -62.33% -38.66% -5.45%
EBIT Margin		 -414.33% -174.58% -169.60% -220.13% -87.70% -62.33% -38.66% -5.45%
Profit (Net Income) Margin		 -415.31% -168.99% -171.11% -220.55% -87.18% -61.09% -38.90% -5.45%
Tax Burden Percent		 100.24% 100.83% 100.44% 100.19% 99.41% 100.77% 100.61% 100.00%
Interest Burden Percent		 100.00% 96.00% 100.44% 100.00% 100.00% 97.26% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -4,577.03% 0.00% 0.00% 0.00% 0.00% -2,127.62% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -4,572.01% 0.00% 0.00% 0.00% 0.00% -2,125.30% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 4,528.44% 0.00% 0.00% 0.00% 0.00% 2,106.61% 0.00% 0.00%
Return on Equity (ROE)		 -48.59% -44.87% -48.55% -60.30% -54.10% -21.01% -50.79% -32.94%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -516.59% 0.00% 0.00%
Operating Return on Assets (OROA)		 -29.21% -13.01% -13.96% -20.48% -9.69% -8.45% -6.36% -1.02%
Return on Assets (ROA)		 -29.28% -12.60% -14.09% -20.52% -9.63% -8.28% -6.40% -1.02%
Return on Common Equity (ROCE)		 -48.39% -44.70% -48.26% -60.11% -53.67% -20.78% -50.32% -32.73%
Return on Equity Simple (ROE_SIMPLE)		 -51.24% 0.00% -60.95% -81.08% -69.80% 0.00% -64.92% -39.22%
Net Operating Profit after Tax (NOPAT)		 -89 -43 -47 -74 -35 -28 -23 -3.64
NOPAT Margin		 -290.26% -119.47% -118.72% -154.09% -61.39% -43.63% -27.06% -3.81%
Net Nonoperating Expense Percent (NNEP)		 -5.02% -2.40% -2.99% -4.89% -2.41% -2.32% -1.78% -0.27%
Cost of Revenue to Revenue		 128.66% 110.34% 134.42% 200.21% 98.44% 85.27% 86.25% 77.70%
SG&A Expenses to Revenue		 61.89% 49.72% 49.75% 45.07% 35.88% 27.29% 21.50% 16.02%
R&D to Revenue		 48.21% 32.12% 29.15% 27.46% 20.62% 16.12% 9.75% 7.33%
Operating Expenses to Revenue		 385.99% 160.34% 135.18% 119.92% 89.25% 77.05% 52.41% 27.75%
Earnings before Interest and Taxes (EBIT)		 -127 -63 -68 -105 -51 -40 -33 -5.20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -123 -59 -63 -100 -46 -35 -27 0.70
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.67 0.53 0.70 0.86 0.46 0.58 1.26 1.29
Price to Tangible Book Value (P/TBV)		 0.74 0.60 0.80 1.02 0.56 0.72 1.61 1.67
Price to Revenue (P/Rev)		 3.66 2.62 2.80 2.50 1.04 1.04 1.74 1.39
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.99 -1.02 -1.03 -1.08 -1.18 -0.99 -1.26 -1.48
Leverage Ratio		 2.13 2.21 2.43 2.76 3.12 3.16 3.45 4.15
Compound Leverage Factor		 2.13 2.12 2.44 2.76 3.12 3.08 3.45 4.15
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.63% 0.61% 0.87% 0.31% 1.05% 1.77% 1.01% 1.12%
Common Equity to Total Capital		 99.37% 99.39% 99.13% 99.69% 98.95% 98.23% 98.99% 98.88%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -0.70 -0.72 -0.80 -1.03 -1.07 -1.29 -1.02 -0.78
Noncontrolling Interest Sharing Ratio		 0.41% 0.39% 0.58% 0.31% 0.79% 1.06% 0.92% 0.66%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 1.00 1.00 0.89 0.72 0.72 0.41 0.71 1.05
Quick Ratio		 1.00 1.00 0.89 0.72 0.72 0.41 0.71 0.99
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2.19 26 67 64 73 -131 56 134
Operating Cash Flow to CapEx		 -781.82% -860.00% -915.38% -27.68% 23.40% -1,077.78% 520.59% -278.95%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.07 0.07 0.08 0.09 0.11 0.14 0.16 0.19
Accounts Receivable Turnover		 1.54 1.46 1.39 1.43 1.54 1.66 1.77 1.98
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 236.35 249.58 263.07 254.55 237.15 219.66 205.69 184.43
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 236.35 249.58 263.07 254.55 237.15 219.66 205.69 184.43
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 -38 -47 -77 -118 -147 56 -156 -255
Invested Capital Turnover		 15.77 -9.65 -6.62 -3.14 -1.95 48.77 -2.19 -1.62
Increase / (Decrease) in Invested Capital		 -91 -69 -114 -137 -109 102 -79 -138
Enterprise Value (EV)		 -249 -323 -237 -179 -365 -105 -63 -161
Market Capitalization		 424 314 378 385 189 218 444 421
Book Value per Share		 $1.11 $25.58 $23.10 $19.15 $17.20 $15.82 $14.45 $13.10
Tangible Book Value per Share		 $1.00 $22.73 $20.22 $16.20 $14.22 $12.65 $11.36 $10.13
Total Capital		 639 594 543 447 411 385 355 330
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -677 -640 -620 -565 -558 -329 -511 -585
Capital Expenditures (CapEx)		 5.50 3.50 3.90 34 4.70 4.50 3.40 3.80
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -571 -522 -554 -650 -631 -551 -551 -553
Debt-free Net Working Capital (DFNWC)		 -3.20 -2.60 -74 -221 -214 -409 -203 33
Net Working Capital (NWC)		 -3.20 -2.60 -74 -221 -214 -409 -203 33
Net Nonoperating Expense (NNE)		 38 18 21 32 15 11 10 1.56
Net Nonoperating Obligations (NNO)		 -677 -640 -620 -565 -558 -329 -511 -585
Total Depreciation and Amortization (D&A)		 3.80 4.00 4.30 5.20 4.90 5.40 5.60 5.90
Debt-free, Cash-free Net Working Capital to Revenue		 -492.92% -436.01% -410.15% -421.95% -348.34% -262.71% -216.24% -182.50%
Debt-free Net Working Capital to Revenue		 -2.76% -2.17% -55.11% -143.38% -118.01% -194.95% -79.73% 10.77%
Net Working Capital to Revenue		 -2.76% -2.17% -55.11% -143.38% -118.01% -194.95% -79.73% 10.77%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 ($5.66) ($2.77) ($3.01) ($4.61) ($2.24) ($1.80) ($1.47) ($0.34)
Adjusted Weighted Average Basic Shares Outstanding		 22.84M 22.75M 23.20M 23.39M 23.73M 23.58M 24.23M 25.07M
Adjusted Diluted Earnings per Share		 ($5.66) ($2.77) ($3.01) ($4.61) ($2.24) ($1.80) ($1.47) ($0.34)
Adjusted Weighted Average Diluted Shares Outstanding		 22.84M 22.75M 23.20M 23.39M 23.73M 23.58M 24.23M 25.07M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($2.77) $0.00 $0.00 $0.00 ($1.80) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 23.06M 23.31M 23.26M 23.67M 23.89M 24.31M 24.43M 24.36M
Normalized Net Operating Profit after Tax (NOPAT)		 -50 -43 -47 -74 -35 -24 -21 -9.38
Normalized NOPAT Margin		 -164.17% -119.47% -118.72% -154.09% -61.39% -37.66% -24.10% -9.82%
Pre Tax Income Margin		 -414.33% -167.60% -170.35% -220.13% -87.70% -60.62% -38.66% -5.45%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% -1.62% 0.00% -2.63% -3.38% -3.65% -7.28% -10.55%
Augmented Payout Ratio		 0.00% -1.62% -0.06% -3.13% -4.01% -4.33% -7.98% -10.55%

Frequently Asked Questions About Hippo's Financials

When does Hippo's financial year end?

According to the most recent income statement we have on file, Hippo's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Hippo's net income changed over the last 3 years?

Hippo's net income appears to be on a downward trend, with a most recent value of -$28.60 million in 2024, falling from -$367.90 million in 2021. The previous period was -$263 million in 2023.

What is Hippo's operating income?
Hippo's total operating income in 2024 was -$81.90 million, based on the following breakdown:
  • Total Gross Profit: $74.30 million
  • Total Operating Expenses: $156.20 million
How has Hippo revenue changed over the last 3 years?

Over the last 3 years, Hippo's total revenue changed from $91.20 million in 2021 to $372.10 million in 2024, a change of 308.0%.

How much debt does Hippo have?

Hippo's total liabilities were at $1.18 billion at the end of 2024, a 3.4% increase from 2023, and a 50.9% increase since 2021.

How much cash does Hippo have?

In the past 3 years, Hippo's cash and equivalents has ranged from $142.10 million in 2023 to $775.60 million in 2021, and is currently $197.60 million as of their latest financial filing in 2024.

How has Hippo's book value per share changed over the last 3 years?

Over the last 3 years, Hippo's book value per share changed from 1.53 in 2021 to 14.86 in 2024, a change of 873.0%.


Related Companies

This page (NYSE:HIPO) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners
Claim Your FREE Protection Guide
In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...
American Alternative | Sponsored
Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...
Colonial Metals | Sponsored
100-year-old investment secret predicts what?!
A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...
Weiss Ratings | Sponsored
The first casualty of the 2025 trade war
The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...
Investors Alley | Sponsored
2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisis
What's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...
Stansberry Research | Sponsored
Is it CRAZY to still want reliable profits, despite this market?
Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...
Brownstone Research | Sponsored
How War with China Could Start in 128 Days
The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...
Behind the Markets | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored